Log In
Print
BCIQ
Print
Print this Print this
 

Xarelto, rivaroxaban (BAY 59-7939)

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionDirect Factor Xa inhibitor
Molecular Target Factor Xa
Mechanism of ActionFactor Xa inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today